Introduction The procedure with tyrosine kinase inhibitors (TKIs) has drastically improved the results of chronic myeloid leukemia (CML) patients. greater than this, sex and competition matched standard human population (SIR 1.30, 95% CI: 1.2C1.40; 0.001). The SIRs for CLL (SIR 3.4, 95% CI: 2C5.5; 0.001), thyroid (SIR 2.2, 95% CI: 1.2C3.5; 0.001), little intestine (SIR… Continue reading Introduction The procedure with tyrosine kinase inhibitors (TKIs) has drastically improved